Controlled trial of two different methylprednisolone doses in cadaveric renal transplantation

A. de Vecchi, E. Rivolta, A. Tarantino, F. Egidi, L. Berardinelli, A. Vegeto, C. Ponticelli

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In a controlled trial the effects of two different methylprednisolone (MP) schedules were studied in 100 cadaver kidney adult recipients followed for 18-46 months. Group A patients were given 160 mg/day i.v. for 3 days, then oral MP (0.8 mg/kg/day), which was tapered by 4 mg/week to a maintenance dose of 16 mg/day up to the 6th month. Group B patients were given 80 mg/day i.v. for 3 days followed by 0.4 mg/kg/day oral MP; the dose was reduced by 2 mg/week to 16 mg/day. In both groups, the dose was further reduced bimonthly to a final dose of 8 mg/day. No significant differences were evidenced between the two groups in patients and kidney survival or in the incidence of complications. The number of patients with at least one rejection episode was significantly higher in the lower dose group.

Original languageEnglish
Pages (from-to)262-266
Number of pages5
JournalNephron
Volume41
Issue number3
Publication statusPublished - 1985

Fingerprint

Methylprednisolone
Kidney Transplantation
Kidney
Cadaver
Appointments and Schedules
Incidence

ASJC Scopus subject areas

  • Nephrology

Cite this

de Vecchi, A., Rivolta, E., Tarantino, A., Egidi, F., Berardinelli, L., Vegeto, A., & Ponticelli, C. (1985). Controlled trial of two different methylprednisolone doses in cadaveric renal transplantation. Nephron, 41(3), 262-266.

Controlled trial of two different methylprednisolone doses in cadaveric renal transplantation. / de Vecchi, A.; Rivolta, E.; Tarantino, A.; Egidi, F.; Berardinelli, L.; Vegeto, A.; Ponticelli, C.

In: Nephron, Vol. 41, No. 3, 1985, p. 262-266.

Research output: Contribution to journalArticle

de Vecchi, A, Rivolta, E, Tarantino, A, Egidi, F, Berardinelli, L, Vegeto, A & Ponticelli, C 1985, 'Controlled trial of two different methylprednisolone doses in cadaveric renal transplantation', Nephron, vol. 41, no. 3, pp. 262-266.
de Vecchi A, Rivolta E, Tarantino A, Egidi F, Berardinelli L, Vegeto A et al. Controlled trial of two different methylprednisolone doses in cadaveric renal transplantation. Nephron. 1985;41(3):262-266.
de Vecchi, A. ; Rivolta, E. ; Tarantino, A. ; Egidi, F. ; Berardinelli, L. ; Vegeto, A. ; Ponticelli, C. / Controlled trial of two different methylprednisolone doses in cadaveric renal transplantation. In: Nephron. 1985 ; Vol. 41, No. 3. pp. 262-266.
@article{a2df1c3c9efe411f88d81b4a52576d9a,
title = "Controlled trial of two different methylprednisolone doses in cadaveric renal transplantation",
abstract = "In a controlled trial the effects of two different methylprednisolone (MP) schedules were studied in 100 cadaver kidney adult recipients followed for 18-46 months. Group A patients were given 160 mg/day i.v. for 3 days, then oral MP (0.8 mg/kg/day), which was tapered by 4 mg/week to a maintenance dose of 16 mg/day up to the 6th month. Group B patients were given 80 mg/day i.v. for 3 days followed by 0.4 mg/kg/day oral MP; the dose was reduced by 2 mg/week to 16 mg/day. In both groups, the dose was further reduced bimonthly to a final dose of 8 mg/day. No significant differences were evidenced between the two groups in patients and kidney survival or in the incidence of complications. The number of patients with at least one rejection episode was significantly higher in the lower dose group.",
author = "{de Vecchi}, A. and E. Rivolta and A. Tarantino and F. Egidi and L. Berardinelli and A. Vegeto and C. Ponticelli",
year = "1985",
language = "English",
volume = "41",
pages = "262--266",
journal = "Experimental Nephrology",
issn = "0028-2766",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Controlled trial of two different methylprednisolone doses in cadaveric renal transplantation

AU - de Vecchi, A.

AU - Rivolta, E.

AU - Tarantino, A.

AU - Egidi, F.

AU - Berardinelli, L.

AU - Vegeto, A.

AU - Ponticelli, C.

PY - 1985

Y1 - 1985

N2 - In a controlled trial the effects of two different methylprednisolone (MP) schedules were studied in 100 cadaver kidney adult recipients followed for 18-46 months. Group A patients were given 160 mg/day i.v. for 3 days, then oral MP (0.8 mg/kg/day), which was tapered by 4 mg/week to a maintenance dose of 16 mg/day up to the 6th month. Group B patients were given 80 mg/day i.v. for 3 days followed by 0.4 mg/kg/day oral MP; the dose was reduced by 2 mg/week to 16 mg/day. In both groups, the dose was further reduced bimonthly to a final dose of 8 mg/day. No significant differences were evidenced between the two groups in patients and kidney survival or in the incidence of complications. The number of patients with at least one rejection episode was significantly higher in the lower dose group.

AB - In a controlled trial the effects of two different methylprednisolone (MP) schedules were studied in 100 cadaver kidney adult recipients followed for 18-46 months. Group A patients were given 160 mg/day i.v. for 3 days, then oral MP (0.8 mg/kg/day), which was tapered by 4 mg/week to a maintenance dose of 16 mg/day up to the 6th month. Group B patients were given 80 mg/day i.v. for 3 days followed by 0.4 mg/kg/day oral MP; the dose was reduced by 2 mg/week to 16 mg/day. In both groups, the dose was further reduced bimonthly to a final dose of 8 mg/day. No significant differences were evidenced between the two groups in patients and kidney survival or in the incidence of complications. The number of patients with at least one rejection episode was significantly higher in the lower dose group.

UR - http://www.scopus.com/inward/record.url?scp=0021971408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021971408&partnerID=8YFLogxK

M3 - Article

VL - 41

SP - 262

EP - 266

JO - Experimental Nephrology

JF - Experimental Nephrology

SN - 0028-2766

IS - 3

ER -